CompletedPhase 3NCT01026220
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
Studying Nodular lymphocyte predominant Hodgkin lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Kara Kelly, MDChildren's Oncology Group
- Intervention
- bleomycin sulfate(biological)
- Enrollment
- 166 target
- Eligibility
- 21 years · All sexes
- Timeline
- 2009 – 2022
Study locations (30)
- Children's Hospital of Alabama, Birmingham, Alabama, United States
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- University of South Alabama, Mobile, Alabama, United States
- Phoenix Childrens Hospital, Phoenix, Arizona, United States
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Southern California Permanente Medical Group, Downey, California, United States
- City of Hope Medical Center, Duarte, California, United States
- Loma Linda University Medical Center, Loma Linda, California, United States
- Miller Children's Hospital, Long Beach, California, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Children's Hospital Central California, Madera, California, United States
- Children's Hospital and Research Center at Oakland, Oakland, California, United States
- Kaiser Permanente-Oakland, Oakland, California, United States
- Childrens Hospital of Orange County, Orange, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01026220 on ClinicalTrials.govOther trials for Nodular lymphocyte predominant Hodgkin lymphoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06098430Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)St. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT05886036Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM TrialNational Cancer Institute (NCI)
See all trials for Nodular lymphocyte predominant Hodgkin lymphoma →